Evidence map›Paper›PMID 28786733›Full record

ArticleHuman vaccines & immunotherapeutics2017

The 2017 Keystone Symposium on HIV Vaccines.

Christopher A Cottrell, Andrew B Ward

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christopher A Cottrella Department of Integrative Structural and Computational Biology , Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, and Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute , La Jolla , CA , USA.
Andrew B Warda Department of Integrative Structural and Computational Biology , Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, and Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute , La Jolla , CA , USA.

Funding

Broadening autologous Tier 2 anti-HIV neutralizing antibodiesF31AI131873 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI COTTRELL, CHRISTOPHER ANDREW · 2017 to 2020
$95k
NIAID NIH HHS F31 AI131873
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adjuvants, ImmunologicAIDS VaccinesAnimalsAntibodies, NeutralizingClinical Trials as TopicDrug DesignHIVHIV AntibodiesHIV InfectionsHumansImmunogenicity, VaccineTreatment OutcomeAdjuvants, ImmunologicAIDS VaccinesAntibodies, NeutralizingHIV AntibodiesadjuvantantibodybnAbgermlineHIV vaccine

Identifiers

PMID28786733
PMCPMC5647986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.